Also, the administration of plasmids expressing IL-21 exhibits significant antitumor activity, mediated by NK cell and T cells, against melanoma fibrosarcoma (54), renal cell carcinoma and mammary carcinoma (42) subcutaneous head and neck squamous cell carcinoma (55). This evidence concerns the gene IL21 and renal cell carcinoma.